直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Unitary Patent System (UPS) and the Unified Patent Court (UPC)

About

To navigate the UPC forum, you need experienced European patent attorneys

Since its launch on 1 June 2023, the Unified Patent Court (UPC) has transformed the landscape of European patent litigation, offering a streamlined forum for enforcing and challenging patents across multiple jurisdictions. Finnegan was among the first firms to file an action in the UPC, demonstrating its deep focus on navigating this new system. Our European patent litigators and European patent attorneys provide comprehensive guidance on UPC strategy, including infringement and revocation actions. Our team is fully authorized to represent clients before the UPC, ensuring robust advocacy in high-stakes disputes. Additionally, we assist clients in opting out (and back in) of the UPC’s jurisdiction during the transitional period, which (unless not prolonged for another seven years) ends in 2030, and tailoring strategies to their specific business needs.

Strategic Advantages of the UPC

The UPC provides a centralized venue for enforcing European patents granted by the European Patent Office (EPO), covering currently 18 European Union member states (i.e., Germany, France, Italy, Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovenia, and Sweden). This unified approach allows patent holders to secure rights across multiple member states through a single court action, significantly reducing litigation complexity and costs.

With Finnegan’s early experience in UPC proceedings, our attorneys emphasize the rapid pace of litigation. Preliminary injunctions—which can apply across multiple UPC member states—are available, making swift strategic action essential for both patentees and challengers.

Revocation Actions and Market Strategy

The UPC is also a powerful forum for revocation of European patents and Supplementary Protection Certificates (SPCs). Companies seeking to clear the path for product launches can leverage the UPC’s jurisdiction to invalidate patents across multiple countries in a single proceeding, offering a decisive advantage in competitive markets.

Unitary Patents: A Game-Changer for Applicants

Coinciding with the UPC’s opening, the EPO began granting European Patents with Unitary Effect (Unitary Patents). These patents provide uniform protection across all 18 participating member states, reducing administrative burdens and lowering maintenance costs compared to traditional national patents. Unitary Patents can be asserted and challenged before the UPC, further enhancing their strategic value.

As the UPC continues to evolve, Finnegan remains at the forefront, leveraging its practical experience to help clients navigate this transformative patent system with confidence.

For more information, visit our Unified Patent Court (UPC) Hub.

Contacts

Dr. Antje Brambrink
Partner
Munich
+49 89 83931 1239
Email
Luigi Distefano
Partner
London
+44 (0)20 7864 2800
Email
Dr. Johannes Druschel
Partner
Munich
+49 89 83931 1232
Email
Dr. Dr. Jochen Herr, LL.M.
Partner
Munich
+49 89 83931 1240
Email
Darren M. Jiron
Partner
London
+44 (0)20 7864 2853
+1 571 203 2729
Email
Dr. Moritz Meckel
Partner
Munich
+49 89 83931 1235
Email
Yelena Morozova
Partner
London
+44 (0)20 7864 2819
Email
Maeve O'Flynn
Partner
London
+44 (0)20 7864 2856
Email
Dr. Antje Brambrink
Partner
Munich
+49 89 83931 1239
Email
Luigi Distefano
Partner
London
+44 (0)20 7864 2800
Email
Dr. Johannes Druschel
Partner
Munich
+49 89 83931 1232
Email
Dr. Dr. Jochen Herr, LL.M.
Partner
Munich
+49 89 83931 1240
Email
Darren M. Jiron
Partner
London
+44 (0)20 7864 2853
+1 571 203 2729
Email
Dr. Moritz Meckel
Partner
Munich
+49 89 83931 1235
Email
Yelena Morozova
Partner
London
+44 (0)20 7864 2819
Email
Maeve O'Flynn
Partner
London
+44 (0)20 7864 2856
Email

Everyone in this practice

Experience

Advised on a patent revocation action relating to an antiepileptic drug*
Advised on a patent revocation action relating to an antiepileptic drug.

Insights

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

European IP Blog

T 0137/24 and Securing Effective Protection for Biologics

1 May 2026

Articles

Schutzschrift Thumbnail

Preempting Surprise Injunctions in Germany and the UPC: Strategic Use of the Schutzschrift in Global Patent Litigation 

March 27, 2026

Conference

IPBC Europe 2026

March 23-25, 2026

Paris

Articles

The UPC - Only Three Years Old and Already Leading

The UPC - Only Three Years Old and Already Leading

March 18, 2026

Articles

SEP Licensing In Europe: Recent Developments

March 5, 2026

More

News

Award/Ranking

Finnegan Wins “Intellectual Property Firm of the Year” at the 2026 Benchmark Litigation Awards

March 12, 2026

Award/Ranking

Finnegan’s Munich Office Earns Recognition in 2026 Best Law Firms – Germany Rankings

September 25, 2025

Press Release

Leading Finnegan IP Litigator Appointed as Managing Partner

June 25, 2025

Media Mention

US Law Firms Race to Dominate Europe’s New Patent Battleground

February 27, 2025

Award/Ranking

Finnegan’s Munich Office Ranks in The Legal 500 Deutschland for Third Consecutive Year

February 13, 2025

Commentary

Leveraging Strength: How U.S. Firms are Recruiting UPC Talent

November 27, 2024

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP